AzTrials
AzTrials

HipFCDNCT05613439

The Fast-track Centre for Hip and Knee Replacement Database

An observational study of Hip and Knee, run by Copenhagen University Hospital, Rigshospitalet at 8 sites in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective study-registry on preoperative patient characteristics and postoperative complications in patients having fast-track hip and knee replacement surgery in 8 Danish dedicated arthroplasty departments from all five health regions in Denmark. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hip, Knee, Fast-track Surgery
What is being tested?
Day-surgery, High-risk patient and Main Group
How many people
45,000 participants
Where
8 sitesDenmark
Study dates
1 Sep 2022to 31 Dec 2025
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The participating dedicated arthroplasty departments are placed in either large university or regional hospitals. The departments cover all five healthcare regions in Denmark and are estimated to contribute with about 40% of the annual hip and knee replacements in Denmark. Thus, the population is representative of the general Danish arthroplasty population.

Who may be able to join

  • age >18 years
  • non-malignant surgery
  • danish social security number
  • elective procedure

Who cannot join

  • unwilling to provide informed consent

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

Denmark8 sites
  • Bispebjerg University Hospital

    Copenhagen, Capital Region

  • Aalborg University Hospital, Farsø

    Farsø, Region of Northern Judland, 9640

  • Gentofte University Hospital

    Gentofte Municipality, Capital Region

  • Gødstrup Hospital

    Herning, Region of Middle Judland

  • Hvidovre Hospital

    Hvidovre, Capital Region, 2650

  • Næstved Hospital

    Næstved, Region Sjælland

  • University Hospital Svendborg

    Svendborg, Region Syddanmark

  • Lillebaelt Hospital, Vejle

    Vejle, Region of Sourthern Denmark, 7100

Other trials in Denmark

About this study

Official title: The Fast-track Centre for Hip and Knee Replacement Prospective Database on Preoperative Patientcharacteristics and Postoperative Complications

This is a prospective study-registry on preoperative patient characteristics and postoperative complications in patients having fast-track hip and knee replacement surgery in 8 Danish dedicated arthroplasty departments from all five health regions in Denmark. The registry consists of detailed patient and physician reported preoperative characteristics and including prescribed medication and lab results. Follow-up is based on electronical medical records by dedicated nurses with physician backup and includes Clavien-Dindo and Comprehensive Complication Index scoring. All patients having day-surgery also completes a patient reported questionaire on health-care utilization and return to work by day 30. Finally, a machine-learning algorithm for identification of "high-risk" patients based on he preoperative data is included.

Read the detailed description

The study registry is intended for further detailed research on postoperative morbidity, feasibility and safety of day surgery and functional outcomes after fast-track hip and knee replacement in 8 dedicated Danish arthroplasty wards across all five health care regions in Denmark. The work is a continuation of the Lundbeck Foundation Centre Database on Hip and Knee Replacement also registered in ClinicalTrials but ceased enrolling in august 2017.

The aim of the registry is to provide standardized and comprehensive information on preoperative patient characteristics and postoperative complications, patient reported outcome measures and health-care utilization in fast-track hip and knee replacement within a socialized health-care system. Each department have dedicated research personel assuring registration and follow-up supervised by a datamanager, and with database-support from the Danish health Region of Southern Denmark.

All departments have similar established fast-track protocols as standard of care, but with focus on dividing patients into day-surgery, main fast-track group and high-risk cohorts.

Preoperative data includes information on prescribed medication, Clinical Frailty Score using CFS v.1, evaluation of Pain Catastrophizing Scale as well as laboratory testing of hemoglobin, kidney function, Hb1Ac in diabetics and C-reactive protein level. On the basis of the collected preoperative data a machine-learning algorithm for identifying the "high-risk" patients is being refined and with planned induction in the database.

Being tested
Day-surgery, High-risk patient, Main Group
Keywords
Hip Replacement, Knee Replacement, Perioperative Medicine, Enhanced Recovery After Surgery, Perioperative/Postoperative Complications, Ambulatory Surgical Procedures
Medical subject headings
Postoperative Complications, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Day-surgeryProcedure or surgery

    Standard surgical procedure but with planned discharge on day of surgery

  • High-risk patientProcedure or surgery

    Standard fast-track procedure but with additional perioperative measures dependent on risk-profile.

  • Main GroupProcedure or surgery

    Standard fast-track procedure according to usual standard of care and discharge when fulfilling functional discharge criteria

Study groups in NCT05613439
Study groupRoleWhat they receive
Day-surgery groupPatients having hip or knee replacement as day-surgery with successful discharge to own home on day of surgery
Receives: Procedure: Day-surgery
High-risk patientsPatients evaluated to be at increased risk of postoperative complications. These patients will receive relevant additional attention based on type of comorbidity. I.e. preoperative evaluation of iron status and i.v. iron treatment in case of preoperative anaemia, increased focus on avoidance of NSAIDs and adequate fluid therapy in patients with renal disease etc.
Receives: Procedure: High-risk patient
Main groupPatients who are not scheduled for day-surgery and without comorbidities qualifying as "high-risk". These patients go through a standard fast-track procedure with discharge to own home when fulfilling functional discharge criteria.
Receives: Procedure: Main Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fraction of unselected patients able to undergo day-surgery procedures

    The fraction patients eligible for day-surgery who are discharged on day of surgery.

    Measured: 7 days postoperatively

  2. postoperative morbidity

    postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery.

    Measured: 90 days postoperatively

  3. postoperative morbidity Clavien-Dindo

    Postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery according to the Clavien-Dindo index.

    Measured: 90 days postoperatively

  4. postoperative morbidity CCI

    Postoperative morbidity resulting in prolonged (>2 days) hospitalisation, readmissions or mortality 90 days after surgery according to the Comprehensive Complication Index

    Measured: 90 days postoperatively

Secondary outcomes (1)
  1. Healthcare utilisation in day-surgery

    Registration of emergency room visits, visits to general practitioners and use of medical emergency services within 30 days after having hip or knee replacement as day-surgery procedure.

    Measured: 30 days postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2022
  2. Study start1 Sep 2022
  3. Primary completion31 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
45,000 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT05613439
Sponsor's protocol ID
FC-1
Acronym
FCD
Status last verified
Jul 2026
First submitted
19 Oct 2022
Last updated
9 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Issa LM, Jorgensen CC, Madsbad S, Lindberg-Larsen M, Varnum C, Jakobsen T, Andersen MR, Bieder MJ, Overgaard S, Hansen TB, Gromov K, Kehlet H. Feasibility of a prospective multicenter observational study-is diabetes a risk factor in ERAS joint arthroplasty? Pilot Feasibility Stud. 2025 Dec 13;12(1):10. doi: 10.1186/s40814-025-01747-w.

    PubMed 41387916
  • Mahmoud LI, Kehlet H, Madsbad S, Lindberg-Larsen M, Varnum C, Jakobsen T, Andersen MR, Bieder MJ, Overgaard S, Hansen TB, Gromov K, Jorgensen CC. Perioperative GLP1-RA management and risk of aspiration in patients with diabetes undergoing fast-track hip and knee arthroplasty. Dan Med J. 2025 Apr 9;72(5):A09240629. doi: 10.61409/A09240629.

    PubMed 40407287
  • Jorgensen CC, Lindberg-Larsen M, Gromov K, Varnum C, Bider MJ, Overgaard S, Andersen MR, Hansen TB, Kehlet H. Association of non-anaemic iron deficiency with postoperative outcomes after fast-track hip and knee arthroplasty: a prospective cohort study. Br J Anaesth. 2025 Aug;135(2):322-330. doi: 10.1016/j.bja.2025.03.039. Epub 2025 May 21.

    PubMed 40404500
  • Issa LM, Kehlet H, Madsbad S, Lindberg-Larsen M, Varnum C, Jakobsen T, Andersen MR, Bieder MJ, Overgaard S, Hansen TB, Gromov K, Jorgensen CC. Protocol for a prospective multicentre cohort study to address the question whether diabetes and its management is still a risk factor in fast-track joint arthroplasty. BMJ Open. 2024 Apr 23;14(4):e080232. doi: 10.1136/bmjopen-2023-080232.

    PubMed 38658012

Questions about this trial

What is this clinical trial studying?

An observational study of Hip and Knee, run by Copenhagen University Hospital, Rigshospitalet at 8 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fraction of unselected patients able to undergo day-surgery procedures (time frame: 7 days postoperatively). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05613439, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in